Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prognosis and Effect of Glipizide vs Metformin on Type-2 Diabetes With Coronary Artery Disease
NCT00513630Phase 4Completed
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Jun 2004
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of glipizide, metformin in type 2 diabetes mellitus (T2DM), sponsored by Shanghai Jiao Tong University School of Medicine. Started Jun 2004; status: completed.
02
Drugs
glipizidemetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00513630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00513630.